Pelvic peritonitis during biologic therapy for rheumatoid arthritis: a case report and review of the literature
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-1801
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Pelvic peritonitis during biologic therapy for rheumatoid arthritis: a case report and review of the literature ; volume:3 ; number:1 ; day:29 ; month:9 ; year:2014 ; pages:1-4 ; date:12.2014
SpringerPlus ; 3, Heft 1 (29.9.2014), 1-4, 12.2014
- Creator
-
Sasaki, Tsuyoshi
Okamura, Koichi
Yonemoto, Yukio
Okura, Chisa
Takagishi, Kenji
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/2193-1801-3-567
- URN
-
urn:nbn:de:101:1-2021081721434406406378
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sasaki, Tsuyoshi
- Okamura, Koichi
- Yonemoto, Yukio
- Okura, Chisa
- Takagishi, Kenji
- SpringerLink (Online service)
Other Objects (12)
Administration costs of intravenous biologic drugs for rheumatoid arthritis
Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis
Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study
Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics
Utilizing biologic disease-modifying anti-rheumatic treatment sequences to subphenotype rheumatoid arthritis
Safety of biologic agents after rituximab therapy in patients with rheumatoid arthritis
Association between autophagy and inflammation in patients with rheumatoid arthritis receiving biologic therapy
Analysis of biologic therapy in rheumatoid arthritis in a southern Spanish hospital population
Discontinuation of Biologic Therapy in Rheumatoid Arthritis: Analysis from the Corrona RA Registry
Patterns of biologic agent utilization among patients with rheumatoid arthritis: a retrospective cohort study
Biologic Disease-Modifying Antirheumatic Drug Prescription Patterns for Rheumatoid Arthritis Among United States Physicians
Administration costs of intravenous biologic drugs for rheumatoid arthritis
Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis
Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study
Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics
Utilizing biologic disease-modifying anti-rheumatic treatment sequences to subphenotype rheumatoid arthritis
Safety of biologic agents after rituximab therapy in patients with rheumatoid arthritis
Association between autophagy and inflammation in patients with rheumatoid arthritis receiving biologic therapy
Analysis of biologic therapy in rheumatoid arthritis in a southern Spanish hospital population
Discontinuation of Biologic Therapy in Rheumatoid Arthritis: Analysis from the Corrona RA Registry
Patterns of biologic agent utilization among patients with rheumatoid arthritis: a retrospective cohort study
Biologic Disease-Modifying Antirheumatic Drug Prescription Patterns for Rheumatoid Arthritis Among United States Physicians
Administration costs of intravenous biologic drugs for rheumatoid arthritis
Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis
Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study
Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics
Utilizing biologic disease-modifying anti-rheumatic treatment sequences to subphenotype rheumatoid arthritis
Safety of biologic agents after rituximab therapy in patients with rheumatoid arthritis
Association between autophagy and inflammation in patients with rheumatoid arthritis receiving biologic therapy
Analysis of biologic therapy in rheumatoid arthritis in a southern Spanish hospital population
Discontinuation of Biologic Therapy in Rheumatoid Arthritis: Analysis from the Corrona RA Registry
Patterns of biologic agent utilization among patients with rheumatoid arthritis: a retrospective cohort study